Unresectable Pancreatic Cancer clinical trials

Explore recruiting unresectable pancreatic cancer clinical trials.

Recruiting unresectable pancreatic cancer studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Unresectable Pancreatic Cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Open label randomized, multicentre, controlled trial of pancreatic enzyme replacement therapy (PERT) for pancreatic exocrine insufficiency (PEI) in patients with unresectable pancreatic cancer.

Spain, France, Italy, Sweden

Therapeutic use (Phase IV) EU CTIS Study details

Effects of calcium electroporation, electrochemotherapy, and irreversible electroporation (IRE-CaCl2, ECT and IRE) on quality of life and progression – free survival in patients with pancreatic cancer" (IREC).

Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

Unresectable Pancreatic Cancer trials by city

Unresectable Pancreatic Cancer clinical trials

Recruiting unresectable pancreatic cancer studies right now

Trial Evaluating the Efficacy and the Safety of FOLFIRINOX3 Treatment in Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer in First Line of Chemotherapy

Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer

A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations

Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer

Feasibility Study of Suizenji, in Patients With Unresectable Pancreatic Ductal Adenocarcinoma (SUNRISE-II)

A First-in-Human Study to Evaluate Implantable Iontophoresis Chemotherapy Delivery Device With Gemcitabine Once Weekly or Twice Weekly in Participants With Pancreatic Cancer

NALIRIFOX+Adebrelimab+PULSAR for Advanced Pancreatic Cancer

Medical Cannabis in Patients With Advanced Pancreatic and Colorectal Cancer

Dual-Target CAR-NK Cells Targeting Mesothelin (MSLN) and MUC1 in Advanced Pancreatic Ductal Adenocarcinoma

Safety and Efficacy of NRT6008 in Patients With Unresectable Locally Advanced Pancreatic Cancer (LAPC) and Advanced Pancreatic Cancer With Lymph Node Metastases

Study of EGFRBi Armed Fresh PBMC in Metastatic or Unresectable Pancreatic Cancer

A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors

Also recruiting in Europe

Open label randomized, multicentre, controlled trial of pancreatic enzyme replacement therapy (PERT) for pancreatic exocrine insufficiency (PEI) in patients with unresectable pancreatic cancer.

Effects of calcium electroporation, electrochemotherapy, and irreversible electroporation (IRE-CaCl2, ECT and IRE) on quality of life and progression – free survival in patients with pancreatic cancer" (IREC).

Unresectable Pancreatic Cancer trials by city

Other conditions